Delivery Order SPE2DE24D0013-SPE2D626F01BU
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 by the Defense Logistics Agency Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This is a child contract under a larger indefinite delivery vehicle, utilizing a firm fixed-price structure with no set-aside designation. The delivery order, identified as XPRSTREPA-10, pertains to diagnostic reagents and test kits for Cepheid's GeneXpert molecular...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $3,400 under contract XPRS4PLEX-10 by the Defense Logistics Agency's Medical Supply Chain on December 3, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a procurement of diagnostic testing supplies from Cepheid, a leading manufacturer of molecular diagnostic systems and reagents specializing in...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $34,000 firm fixed-price delivery order (Contract 4570371726, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. This delivery order, which carries no set-aside designation, is issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,482.28 by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $2,304.20 by the Defense Logistics Agency Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning in the...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,530.08 by the Defense Logistics Agency's Medical Supply Chain on November 24, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work performed at Cepheid's Sunnyvale, CA facility. As a manufacturer of advanced molecular diagnostic systems and reagents, Cepheid delivers diagnostic...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,800 on January 6, 2026, under a Defense Logistics Agency Medical Supply Chain contract. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic systems and reagents. The award carries no set-aside designation, reflecting Cepheid's competitive positioning...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F01BUDelivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,024.00 under contract XPRSTREPA-10 by the Defense Logistics Agency's Medical Supply Chain on January 11, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price delivery order, which is a child contract with no set-aside designation, represents a specific procurement action for diagnostic testing supplies under Cepheid's larger indefinite delivery contract framework with the Department of Veterans Affairs. As a leading federal supplier of molecular diagnostic systems and reagents, Cepheid specializes in advanced infectious disease detection solutions, including its GeneXpert diagnostic platform and associated test kits for COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other conditions. The delivery order will be performed in Sunnyvale, California, reflecting Cepheid's operational base. Cepheid has established itself as a primary federal supplier to multiple healthcare agencies, including the Veterans Health Administration, Indian Health Service, Defense Health Agency, and U.S. Coast Guard, with extensive prior contract awards demonstrating substantial capability in supplying diagnostic equipment, reagents, and maintenance services across distributed federal medical networks. The company currently holds significant indefinite delivery contracts with the VA, including a $32.8 million single-award contract with VISN 6 extending through September 2030, which serves as the primary vehicle for ongoing procurement of molecular diagnostic testing solutions across VA medical centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/10/26 |